Verastem reported $171.2M in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbvie ABBV:US $ 270.65B 15.68B
AstraZeneca AZN:LN 16734.4B 1035.33B
Curis CRIS:US $ 0.09B 0.13B
Cytokinetics CYTK:US $ 3.36B 0.22B
Epizyme EPZM:US $ 0.25B 0.06B
Gilead Sciences GILD:US $ 77.53B 2.87B
Immunogen IMGN:US $ 0.99B 0.06B
Laboratory Of America LH:US $ 21.33B 3.24B
Novartis NOVN:VX 194.34B 3.46B
Pfizer PFE:US $ 294.18B 1.79B
Roche Holding ROG:VX 300.5B 1.25B
Tg Therapeutics TGTX:US $ 0.61B 0.74B
Verastem VSTM:US $ 0.22B 0.05B
YTE INCY:US $ 16.83B 0.75B
Ziopharm Oncology ZIOP:US $ 0.27B 0.13B